Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
1.
J Environ Manage ; 345: 118572, 2023 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-37421720

RESUMO

Intercropping can favour the yield of the main crop. However, because of the potential competition among woody crops, this system is rarely used by farmers. To increase knowledge about the intercropping system, we have explored three different combinations of alley cropping in rainfed olive groves compared to conventional management (CP): (i) Crocus sativus (D-S); (ii) Vicia sativa/Avena sativa in annual rotation (D-O); and (iii) Lavandula x intermedia (D-L). Different soil chemical properties were analyzed to evaluate the effects of alley cropping, while 16S rRNA amplification and enzymatic activities were determined to study the changes that occurred in soil microbial communities and activity. In addition, the influence of intercropping on the potential functionality of the soil microbial community was measured. Data revealed that the intercropping systems highly affected the microbial community and soil properties. The D-S cropping system increased soil total organic carbon and total nitrogen that were correlated with the bacterial community, indicating that both parameters were the main drivers shaping the structure of the bacterial community. The D-S soil cropping system had significantly higher relative abundances of the phyla Bacteroidetes, Proteobacteria, and Patescibacteria compared to the other systems and the genera Adhaeribacter, Arthrobacter, Rubellimicrobium, and Ramlibacter, related to C and N functions. D-S soil was also related to the highest relative abundances of Pseudoarthrobacter and Haliangium, associated with the plant growth-promoting effect, antifungal activity, and a potential P solubilizer. A potentially increase of C fixation and N fixation in soils was also observed in the D-S cropping system. These positive changes were related to the cessation of tillage and the development of a spontaneous cover crop, which increased soil protection. Thus, management practices that contribute to increasing soil cover should be encouraged to improve soil functionality.


Assuntos
Crocus , Olea , Solo/química , Olea/genética , Crocus/genética , RNA Ribossômico 16S/genética , Bactérias/genética , Produtos Agrícolas , Microbiologia do Solo
2.
Environ Res ; 215(Pt 3): 114382, 2022 12.
Artigo em Inglês | MEDLINE | ID: mdl-36174756

RESUMO

This study aims to show the effect of conventional tillage (CT) in olive orchards in the medium term (15 years) on carbon (C) storage considering the complete soil profile, on the soil C sequestration and stabilisation capacity and on the viability for the achievement of Objective 4‰. The results obtained showed important losses in soil organic carbon (SOC) and SOC stock (SOC-S), with a significant loss of total SOC-S of 42.3%. Concerning the SOC and the SOC-S linked to the fine soil fraction (<20 µm), the evolution over time led however to a SOC increase in depth (BC and C horizons) of 58.3% and 20.9% and increases in SOC-S of 17.2%, 34.7% and 27.3% for the Ap, BC and C horizons, respectively. Finally, it was seen that the goals set by the 4‰ initiative were not met, as losses of 2.1 Mg C ha-1 yr-1 were found when considering the entire soil profile and 0.8 Mg C ha-1 yr-1 when considering only the first 40 cm. Therefore, we can affirm that medium-term CT has not only conditioned C storage in the soils studied, but also their capacity for sequestration and stabilisation, which has repercussions not only on the failure to meet the objectives of the 4‰ initiative, but also on the amount of C lost in 15 years.


Assuntos
Olea , Solo , Agricultura/métodos , Carbono , Sequestro de Carbono
3.
Sci Total Environ ; 758: 143591, 2021 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-33248776

RESUMO

The 4‰ initiative implementation has increased the emphasis and interest in soil carbon and nitrogen storage in the last few years. This study evaluated the dynamics of soil organic carbon and total nitrogen under rain-fed olive groves over a long-term period (2004-2019). The management practices associated with achieving the 4‰ initiative objectives and the depth of analysis to measure the effectiveness of the initiative have generated uncertainties and wide debate in the scientific community. To contribute to this debate from a farm level, the objective of this study was to analyse the effects of conventional tillage and no-tillage with bare soil by using herbicides (after land management change from conventional tillage) on carbon and nitrogen stocks in complete soil profiles (depth > 100 cm) over 15 years in a Mediterranean olive grove. Soil samples were collected from each farm and analysed for carbon content and physical-chemical characteristics. This study indicates that management practices evaluated resulted in soil organic carbon and total nitrogen contents decreasing in soil, with a reduction >30% in all horizons. Results highlight a significant depletion of soil organic carbon stock with a significant decarbonisation process (-1.8 Mg C ha-1 yr-1) and total nitrogen stock (-0.57 and - 0.41 Mg N ha-1 yr-1) on average under both managements (no-tillage no tillage with herbicide and conventional tillage respectively) as compared to the initial situation. Furthermore, it was demonstrated that deep horizons are significant reservoirs of carbon (>50% in all cases) and in woody crops, its analysis within the dynamics of soil organic carbon stocks proposed by the 4‰ initiative was relevant. With these results, no-tillage with bare soil by using herbicides was demonstrated as an unsustainable agricultural practice and it is proposed to change the current soil management to sustainable management that increases the C inputs to achieve the 4‰ targets.

4.
Sci Total Environ ; 744: 140683, 2020 Nov 20.
Artigo em Inglês | MEDLINE | ID: mdl-32721665

RESUMO

The spatial distribution of soil organic carbon (SOC) is essential to estimate the SOC reserves. Therefore, the soils ability to store organic carbon is a key factor for climate regulation and for other soil functions. The soil management and the topographic position play an important role in SOC variation, especially when the landscape is not uniform (Mediterranean areas). Many researches have explored the SOC distribution according to topographic position in hillsides for long-term, but very few studies have focused on the short term. Therefore, it is necessary to know, the changes that taking place in the soil due to land management change (LMC) in these irregular surfaces for sustainable agricultural production and its implications on climate change regulation. This study aims to assess the influence of topographic position and LMC on SOC stock (SOC-S) in Mediterranean olive groves (OG) soils in short term (2 years). In this line, three experimental plots were selected in three topographical position (summit - S, backslope - B and toeslope - T). In these plots, the land management was modified from conventional tillage (CT) to no tillage (NT) with application of pruned olive branch chippings branches and vegetation cover (spontaneous vegetation) in the OG streets. The studied soils did not show important changes due to LMC in their physical properties for short term, in addition, these soils were characterized by low organic matter content (<1.2%). LMC caused a SOC reduction in surface, and a SOC increase in the Bw horizon. The N concentrations showed a similar trend to SOC and the C:N ratios were highly variable (4.37: C horizon-NT-S; 13.45 Bw/C horizon -CT-B). Normally, the SOC-S concentrations decreasing in depth. LMC for two years showed soil carbonization (S and T position) and decarbonization (B position) processes. The SOC-S increased 1.88 Mg ha-1 y-1 and 0.47 Mg ha-1 y-1 for S and T topographic position respectively, however the SOC-S decreased in B position 5.27 Mg ha-1 y-1. Therefore, LMC has a positive effect on soil carbon reserves in S and T position, conversely in B position, this effect was negative.

6.
J Clin Oncol ; 26(3): 447-54, 2008 Jan 20.
Artigo em Inglês | MEDLINE | ID: mdl-18086797

RESUMO

PURPOSE: The heterogeneity of diffuse large B-cell lymphoma (DLBCL) has prompted the search for new markers that can accurately separate prognostic risk groups. We previously showed in a multivariate model that LMO2 mRNA was a strong predictor of superior outcome in DLBCL patients. Here, we tested the prognostic impact of LMO2 protein expression in DLBCL patients treated with anthracycline-based chemotherapy with or without rituximab. PATIENTS AND METHODS: DLBCL patients treated with anthracycline-based chemotherapy alone (263 patients) or with the addition of rituximab (80 patients) were studied using immunohistochemistry for LMO2 on tissue microarrays of original biopsies. Staining results were correlated with outcome. RESULTS: In anthracycline-treated patients, LMO2 protein expression was significantly correlated with improved overall survival (OS) and progression-free survival (PFS) in univariate analyses (OS, P = .018; PFS, P = .010) and was a significant predictor independent of the clinical International Prognostic Index (IPI) in multivariate analysis. Similarly, in patients treated with the combination of anthracycline-containing regimens and rituximab, LMO2 protein expression was also significantly correlated with improved OS and PFS (OS, P = .005; PFS, P = .009) and was a significant predictor independent of the IPI in multivariate analysis. CONCLUSION: We conclude that LMO2 protein expression is a prognostic marker in DLBCL patients treated with anthracycline-based regimens alone or in combination with rituximab. After further validation, immunohistologic analysis of LMO2 protein expression may become a practical assay for newly diagnosed DLBCL patients to optimize their clinical management.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Proteínas de Ligação a DNA/metabolismo , Linfoma Difuso de Grandes Células B/tratamento farmacológico , Linfoma Difuso de Grandes Células B/metabolismo , Metaloproteínas/metabolismo , Proteínas Adaptadoras de Transdução de Sinal , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Anticorpos Monoclonais/administração & dosagem , Anticorpos Monoclonais Murinos , Biomarcadores Tumorais , Estudos de Coortes , Ciclofosfamida/administração & dosagem , Doxorrubicina/administração & dosagem , Humanos , Técnicas Imunoenzimáticas , Proteínas com Domínio LIM , Linfoma Difuso de Grandes Células B/mortalidade , Pessoa de Meia-Idade , Prednisona/administração & dosagem , Prognóstico , Proteínas Proto-Oncogênicas , Proteínas Proto-Oncogênicas c-bcl-6/metabolismo , Rituximab , Taxa de Sobrevida , Análise Serial de Tecidos , Resultado do Tratamento , Vincristina/administração & dosagem
8.
Lung Cancer ; 53(3): 347-53, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16844257

RESUMO

BACKGROUND AND AIMS: Platinum-based doublets are recommended as treatment for advanced or metastatic non-small-cell lung cancer (NSCLC); however, chemotherapy must be tailored to limit side effects. A phase II study was conducted to evaluate the efficacy and safety of oxaliplatin combined with docetaxel for NSCLC. METHODS: Patients with stage IIIB or IV, chemotherapy-naive NSCLC received docetaxel 70 mg/m(2), oxaliplatin 130 mg/m(2), and pegfilgrastim 6 mg every 21 days for up to six cycles. Primary endpoint was overall response rate (ORR), secondary endpoints were progression-free (PFS) and overall survival (OS), and safety. RESULTS: Twenty-nine patients were treated; 93% had stage IV disease and 28% had brain metastases. In 27 evaluable patients with follow-up, there were 10 partial responses for an ORR of 37% (90% confidence interval [CI], 22-55%). Median PFS was 4.6 months (95% CI, 2.6-6.5 months); 12-month PFS was 14.8% (95% CI, 3.4-34.0%). Median OS was 10.9 months (95% CI, 8.9-16.8 months); 12-month OS was 40% (95% CI, 19-61%) and 18-month OS was 16% (95% CI, 1-46%). In 29 treated patients, there were no unusual or unexpected adverse events. The most common grade 3 and 4 toxicities were anemia (14% of patients) and hyperglycemia (10%); there were only two reports of neutropenia; both were grade 1 or 2. CONCLUSION: These phase II findings suggest that the combination of oxaliplatin and docetaxel is active and well tolerated, and should be further investigated as a feasible treatment alternative for patients with advanced or metastatic NSCLC.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico , Compostos Organoplatínicos/administração & dosagem , Taxoides/administração & dosagem , Adulto , Idoso , Progressão da Doença , Intervalo Livre de Doença , Docetaxel , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Modelos Estatísticos , Metástase Neoplásica , Oxaliplatina , Resultado do Tratamento
9.
Blood ; 107(2): 467-72, 2006 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-16166588

RESUMO

Non-Hodgkin lymphomas are among the most common primary tumors occurring in the ocular adnexa. Herein, we present a 14-year single-institution experience in 62 patients with primary ocular adnexal lymphomas (OALs). Association with Chlamydia psittaci infection is examined in 57 tumor specimens. Extranodal marginal zone lymphoma (EMZL) was the most frequent histologic subtype (89%). The majority of patients with EMZL (84%) presented with stage E-extranodal (IE), however only 16% had an advanced stage. All stage IE patients were treated with local radiotherapy, whereas patients with disseminated disease received systemic therapy with or without local irradiation. All but 1 patient with EMZL achieved complete remission (CR). During a median follow-up of 52 months (range, 3-153 months), the estimated 5-year overall survival (OS) and freedom from progression (FFP) were 96% and 79%, respectively. During the follow-up, 22% of patients relapsed, mainly in extranodal sites, and 4% transformed to diffuse large B-cell lymphoma. None of the patients exhibited local orbital failure in the radiation field. None of the OAL specimens harbored C psittaci DNA. Our study demonstrates that EMZLs, accounting for the majority of primary OALs, are characterized by an indolent natural history with frequent, continuous extranodal relapses. In South Florida, OALs are not associated with C psittaci infections.


Assuntos
Neoplasias Oculares/microbiologia , Linfoma de Zona Marginal Tipo Células B/microbiologia , Psitacose/microbiologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Chlamydophila psittaci/genética , Chlamydophila psittaci/isolamento & purificação , Estudos de Coortes , Terapia Combinada , Neoplasias da Túnica Conjuntiva/microbiologia , Neoplasias da Túnica Conjuntiva/patologia , Neoplasias da Túnica Conjuntiva/terapia , Neoplasias Oculares/patologia , Neoplasias Oculares/terapia , Feminino , Humanos , Doenças do Aparelho Lacrimal/microbiologia , Doenças do Aparelho Lacrimal/patologia , Doenças do Aparelho Lacrimal/terapia , Linfoma de Células B/microbiologia , Linfoma de Células B/patologia , Linfoma de Células B/terapia , Linfoma de Zona Marginal Tipo Células B/patologia , Linfoma de Zona Marginal Tipo Células B/terapia , Linfoma Difuso de Grandes Células B/microbiologia , Linfoma Difuso de Grandes Células B/patologia , Linfoma Difuso de Grandes Células B/terapia , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Neoplasias Orbitárias/microbiologia , Neoplasias Orbitárias/patologia , Neoplasias Orbitárias/terapia , Prognóstico , Psitacose/patologia , Psitacose/terapia , Fatores de Risco , Taxa de Sobrevida , Resultado do Tratamento
10.
Leuk Lymphoma ; 46(11): 1651-7, 2005 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16334908

RESUMO

Primary lymphomas of the cranial dura mater are rare. Mucosa-associated lymphoid tissue extranodal marginal zone lymphomas are the most common subtype of non-Hodgkin's lymphomas that present as primary cranial dura tumors. A 33 year-old male presented with a 3-month history of a growing lump in the right frontal area. Neuroimaging studies demonstrated an extra-axial, broad-based mass with a dural tail in the right frontal bone convexity. Biopsy led to the diagnosis of localized dural precursor B-cell lymphoblastic lymphoma. The patient was treated with a combination of chemotherapy and radiotherapy, achieving durable disease-free survival. This is the first report of precursor B-cell lymphoblastic lymphoma of dura mater. A review of the literature on primary lymphomas of cranial dura mater is presented. Primary lymphomas of the cranial dura mater are rare. Mucosa-associated lymphoid tissue extranodal marginal zone lymphomas are the most common subtype of non-Hodgkin's lymphomas that present as primary cranial dura tumors. A 33 year-old male presented with a 3-month history of a growing lump in the right frontal area. Neuroimaging studies demonstrated an extra-axial, broad-based mass with a dural tail in the right frontal bone convexity. Biopsy led to the diagnosis of localized dural precursor B-cell lymphoblastic lymphoma. The patient was treated with a combination of chemotherapy and radiotherapy, achieving durable disease-free survival. This is the first report of precursor B-cell lymphoblastic lymphoma of dura mater. A review of the literature on primary lymphomas of cranial dura mater is presented.


Assuntos
Neoplasias do Sistema Nervoso Central/patologia , Dura-Máter/patologia , Adulto , Antineoplásicos/uso terapêutico , Neoplasias do Sistema Nervoso Central/diagnóstico , Neoplasias do Sistema Nervoso Central/terapia , Intervalo Livre de Doença , Humanos , Imunofenotipagem , Linfoma de Células B , Imageamento por Ressonância Magnética , Masculino , Leucemia-Linfoma Linfoblástico de Células Precursoras , Radioterapia Adjuvante
11.
Blood ; 105(7): 2924-32, 2005 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-15591113

RESUMO

Diffuse large B-cell lymphomas (DLBCLs) can be subclassified into germinal center B-cell (GCB)-like and activated B-cell (ABC)-like tumors characterized by long and short survival, respectively. In contrast to ABC-like DLBCL, GCB-like tumors exhibit high expression of components of the interleukin 4 (IL-4) signaling pathway and of IL-4 target genes such as BCL6 and HGAL, whose high expression independently predicts better survival. These observations suggest distinct activity of the IL-4 signaling pathway in DLBCL subtypes. Herein, we demonstrate similar IL-4 expression but qualitatively different IL-4 effects on GCB-like and ABC-like DLBCL. In GCB-like DLBCL, IL-4 induces expression of its target genes, activates signal transducers and activators of transcription 6 (STAT6) signaling, and increases cell proliferation. In contrast, in the ABC-like DLBCL, IL-4 activates AKT, decreases cell proliferation by cell cycle arrest, and does not induce gene expression due to aberrant Janus kinase (JAK)-STAT6 signaling attributed to STAT6 dephosphorylation. We found distinct expression profiles of tyrosine phosphatases in DLBCL subtypes and identified putative STAT6 tyrosine phosphatases-protein tyrosine phosphatase nonreceptor type 1 (PTPN1) and PTPN2, whose expression is significantly higher in ABC-like DLBCL. These differences in tyrosine phosphatase expression might underlie distinct expression profiles of some of the IL-4 target genes and could contribute to a different clinical outcome of patients with GCB-like and ABC-like DLBCLs.


Assuntos
Linfócitos B/fisiologia , Centro Germinativo/patologia , Interleucina-4/genética , Linfoma de Células B/fisiopatologia , Linfoma Difuso de Grandes Células B/fisiopatologia , Transdução de Sinais/imunologia , Transporte Ativo do Núcleo Celular , Linfócitos B/patologia , Divisão Celular/imunologia , Núcleo Celular/metabolismo , Núcleo Celular/patologia , Regulação Neoplásica da Expressão Gênica , Humanos , Linfoma de Células B/genética , Linfoma de Células B/patologia , Linfoma Difuso de Grandes Células B/genética , Linfoma Difuso de Grandes Células B/patologia , Análise de Sequência com Séries de Oligonucleotídeos , Fosforilação , Proteína Tirosina Fosfatase não Receptora Tipo 1 , Proteínas Tirosina Fosfatases/metabolismo , Fator de Transcrição STAT6 , Transativadores/metabolismo
13.
Leuk Lymphoma ; 45(12): 2459-64, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15621760

RESUMO

The etiology of non-Hodgkin's lymphoma is unknown in the majority of the cases. Although Epstein-Barr virus, human T-cell leukemia-lymphoma virus and human herpes virus-8 have been established as casual agents in the pathogenesis of specific types of lymphoma, the role of hepatitis C virus (HCV) in lymphomagenesis remains controversial, with marked geographic variability. We conducted an epidemiologic study to evaluate the prevalence of hepatitis C virus infection in patients with lymphoma in South Florida. Ninety consecutive patients with lymphoma and 96 consecutive control patients with solid tumors were tested for HCV. HCV infection was detected in 2 patients with NHL (2.2%) and in 4 control patients (4.1%). Our study does not support the association between HCV and lymphoma in South Florida, US.


Assuntos
Hepatite C/complicações , Hepatite C/epidemiologia , Linfoma não Hodgkin/complicações , Linfoma não Hodgkin/patologia , Estudos de Casos e Controles , Feminino , Florida/epidemiologia , Hepatite C/patologia , Hepatite C/virologia , Humanos , Masculino , Pessoa de Meia-Idade , Grupos Raciais
14.
Leuk Lymphoma ; 45(6): 1275-8, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15360012

RESUMO

Non-gastric stage I extranodal marginal zone lymphomas of MALT are usually treated with local therapy. However, distant relapses in other extranodal sites are not uncommon suggesting under-staging of these patients using conventional image studies. Positron emission tomography (PET) scans are frequently negative in this subgroup of patients with lymphoma and therefore do not significantly contribute to the staging process. We present a case of lacrimal gland MALT lymphoma demonstrating the usefulness of somatostatin receptor scintigraphy for initial staging and evaluation of response to treatment.


Assuntos
Anticorpos Monoclonais/uso terapêutico , Antineoplásicos/uso terapêutico , Neoplasias Oculares/diagnóstico por imagem , Doenças do Aparelho Lacrimal/diagnóstico por imagem , Linfoma de Zona Marginal Tipo Células B/diagnóstico por imagem , Octreotida/análogos & derivados , Ácido Pentético/análogos & derivados , Compostos Radiofarmacêuticos , Adulto , Anticorpos Monoclonais Murinos , Neoplasias Oculares/tratamento farmacológico , Feminino , Humanos , Radioisótopos de Índio , Doenças do Aparelho Lacrimal/tratamento farmacológico , Linfoma de Zona Marginal Tipo Células B/tratamento farmacológico , Estadiamento de Neoplasias , Cintilografia , Receptores de Somatostatina/metabolismo , Rituximab , Tomografia Computadorizada de Emissão
16.
Leuk Lymphoma ; 45(5): 1049-53, 2004 May.
Artigo em Inglês | MEDLINE | ID: mdl-15291366

RESUMO

Primary diffuse large cell lymphoma of the mandible is a rare form of extranodal non-Hodgkin's lymphoma (NHL). Herein we present 4 cases treated at our institution over a 5-year period and review 40 cases previously reported in the English-literature. The median age at presentation is 51 years with equal distribution between males and females. At presentation the lymphoma is usually limited to the jaw (stage IE) and the most common presenting symptoms include swelling of the jaw (58%), pain (53%), and mental dysesthesia or numbness (20%). Despite symptoms of numb chin syndrome, central nervous system (CNS) involvement at presentation has not been reported. The reported therapy of this rare diffuse large cell lymphoma presentation is very heterogeneous, however majority of patients were treated with combination of chemotherapy and radiotherapy with estimated 5-year overall survival of only 60%. Multi-center prospective clinical trials are needed to determine the optimal therapeutic approach to this rare diffuse large cell lymphoma presentation.


Assuntos
Linfoma Difuso de Grandes Células B/diagnóstico , Neoplasias Mandibulares/diagnóstico , Adulto , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Feminino , Humanos , Linfoma Difuso de Grandes Células B/tratamento farmacológico , Masculino , Neoplasias Mandibulares/tratamento farmacológico , Pessoa de Meia-Idade , Análise de Sobrevida , Resultado do Tratamento
17.
Am J Hematol ; 76(4): 383-5, 2004 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-15282674

RESUMO

We report herein a patient with coronary artery disease that developed heparin-induced thrombocytopenia after coronary artery bypass graft with resulting thrombosis of multiple saphenous vein grafts and myocardial infarction after heparin exposure. The patient required lepirudin and a cardiac catheterization with placement of stents.


Assuntos
Anticoagulantes/efeitos adversos , Doenças Autoimunes/induzido quimicamente , Ponte de Artéria Coronária , Heparina de Baixo Peso Molecular/efeitos adversos , Infarto do Miocárdio/etiologia , Complicações Pós-Operatórias/etiologia , Trombocitopenia/induzido quimicamente , Trombose/etiologia , Angina Pectoris/cirurgia , Angioplastia com Balão , Anticoagulantes/administração & dosagem , Anticoagulantes/uso terapêutico , Autoanticorpos/sangue , Autoanticorpos/imunologia , Autoantígenos/imunologia , Doenças Autoimunes/imunologia , Cateterismo Cardíaco , Ponte de Artéria Coronária/métodos , Reestenose Coronária/complicações , Reestenose Coronária/terapia , Quimioterapia Combinada , Eptifibatida , Heparina de Baixo Peso Molecular/administração & dosagem , Heparina de Baixo Peso Molecular/uso terapêutico , Hirudinas/análogos & derivados , Humanos , Anastomose de Artéria Torácica Interna-Coronária , Masculino , Pessoa de Meia-Idade , Peptídeos/administração & dosagem , Peptídeos/uso terapêutico , Fator Plaquetário 4/imunologia , Proteínas Recombinantes/uso terapêutico , Recidiva , Veia Safena/transplante , Stents , Trombocitopenia/complicações , Trombocitopenia/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...